Medly Pharmacy Secures Series A Funding to Expand Digital Pharmacy Platform and Enhance Healthcare Efficiency

VCBeat (WeChat Official Account: vcbeat) learned from foreign media that on June 4, U.S. local time, the biopharmaceutical company Medly Pharmacy completed its Series A financing. The funds from this round will be used to support the company in expanding the market share of its medication delivery platform.

It is reported that Greycroft led this round of financing.

Medly Pharmacy, headquartered in New York, USA, is a biopharmaceutical company dedicated to improving the distribution of prescription medications and accelerating drug delivery.

Medly Pharmacy’s services are primarily focused online; customers can download the app, register a personal account, and submit their required prescription medications through the company’s platform, which provides scheduled home delivery.

At a time when medical resources remain insufficient, many patients have experienced delayed treatment due to the inability to afford high-cost prescription medications, while shortages of certain drugs have forced patients to resort to informal channels for procurement. Medly Pharmacy collaborates with multiple healthcare institutions and pharmacies to pre-purchase medications from relevant authorities based on prescriptions collected through its platform, thereby ensuring an adequate supply of drugs for patients at original or reduced prices.

Medly Pharmacy’s services include free same-day delivery, medication refill management, coordination with doctors and insurance providers, prior authorization support, medical consultation services, and financial assistance for medical costs.

Beyond simple medication delivery, Medly Pharmacy is equipped with a professional medical research team that helps patients manage their health scientifically by integrating prescription data. Upon receiving the patient's medication list, researchers customize a full-cycle medication regimen tailored to the specific condition and proactively plan the medication usage schedule to prevent disease exacerbation caused by improper drug use.

Furthermore, for patients unable to reach medical institutions in a timely manner, the Medly Pharmacy platform provides online consultations and issues professional prescriptions, offering comprehensive services ranging from diagnosis to medication delivery. This approach leverages scientific methods to optimize healthcare models and improve the utilization of medical resources.

“Many thanks to our new investors for their support. Medly Pharmacy is at a critical stage of development, and we will leverage the funds from this financing round to further expand our business, forge partnerships with more healthcare institutions and pharmacies, and provide high-quality pharmaceutical distribution services to patients across China,” said Dr. Marg Patel, CEO and Co-Founder of Medly Pharmacy.

Ian Sigalow, Co-Founder and Partner at Greycroft, stated, “Medly Pharmacy has grown rapidly since its inception and has achieved a substantial market share in the pharmaceutical distribution industry. We are eager to collaborate with them to build the premier biopharmaceutical company in the United States.”

Greycroft, founded in 2006 and headquartered in New York, USA, is a venture capital firm with offices in New York and Los Angeles. It focuses on investing in early- and late-stage startups in the internet and technology sectors. To date, it has completed 445 investments and manages over $1 billion in assets.

(Compiled by Liu Yujing)